Religrast 300mcg Injection
Prescription Required
Product introduction
Religrast 300mcg Injection is used to prevent infections after chemotherapy. It is a growth factor that stimulates the bone marrow to produce white blood cells. These cells protect the body against infections.
Religrast 300mcg Injection is used after cancer treatment, if the level of white blood cells is too low, used to increase blood stem cells in the body or used after a bone marrow transplant
Religrast 300mcg Injection is used after cancer treatment, if the level of white blood cells is too low, used to increase blood stem cells in the body or used after a bone marrow transplant
Uses of Religrast Solution for Injection
- Prevention of Infections after chemotherapy
Benefits of Religrast Solution for Injection
In Prevention of Infections after chemotherapy
Religrast 300mcg Injection increases the production of white blood cells by stimulating the immune system in our body. White blood cells are those cells that help us to fight infections. This medicine is really effective and must be used under medical supervision. Avoid being in crowds and wash your hands often to prevent any infections. Have plenty of fluids, unless otherwise advised by the doctor not to.
Side effects of Religrast Solution for Injection
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Religrast
- Bone pain
- Weakness
- Headache
- Rash
- Nausea
- Increased lactate dehydrogenase level in blood
- Vomiting
- Increased uric acid level in blood
- Oropharyngeal pain
- Hair loss
- Fatigue
- Diarrhea
- Constipation
- Decreased appetite
- Cough
- Breathing problems
- Injection site reactions (pain, swelling, redness)
How to use Religrast Solution for Injection
Your doctor or nurse will guide you how to use this medicine.
Safety advice
Alcohol
CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Religrast 300mcg Injection. Please consult your doctor.
Pregnancy
CONSULT YOUR DOCTOR
Religrast 300mcg Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
SAFE IF PRESCRIBED
Religrast 300mcg Injection is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Driving
UNSAFE
Religrast 300mcg Injection may cause side effects which could affect your ability to drive.
Religrast 300mcg Injection may cause fatigue. This may affect your driving ability.
Religrast 300mcg Injection may cause fatigue. This may affect your driving ability.
Kidney
SAFE IF PRESCRIBED
Religrast 300mcg Injection is safe to use in patients with kidney disease. No dose adjustment of Religrast 300mcg Injection is recommended.
Liver
SAFE IF PRESCRIBED
Religrast 300mcg Injection is safe to use in patients with liver disease. No dose adjustment of Religrast 300mcg Injection is recommended.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
No substitutes found for this medicine
Quick tips
- Religrast 300mcg Injection reduces the risk of infection in people treated with chemotherapy.
- It is usually given as a daily injection into the tissue just under the skin or into the vein.
- You will normally receive your first dose at least 24 hours after your chemotherapy or bone marrow transplant.
- Store it in the refrigerator, protect it from light, and don't shake it.
- For a more comfortable injection, leave the syringe at room temperature for 30 minutes before using it.
- Pain or redness in the area of injection is common. Let your doctor know if you notice a lump, swelling, or bruising that doesn't go away.
- Use caution while driving or doing anything that requires concentration as Religrast 300mcg Injection may cause dizziness.
- Your doctor may get regular tests done to monitor the number of blood cells in your blood, and your bone density level while you are receiving treatment with this medicine.
- Stop taking Religrast 300mcg Injection and inform your doctor if you have a fever, shortness of breath, fast rate of breathing or trouble breathing.
Fact Box
Chemical Class
Granulocyte Colony-Stimulating Factor
Habit Forming
No
Therapeutic Class
ANTI NEOPLASTICS
Action Class
Granulocyte-colony stimulating factor (G-CSF)
Patient concerns
User feedback
Patients taking Religrast 300mcg Injection
Once A Week
35%
Once A Day
29%
Once A Month
18%
Thrice A week
6%
Twice A Week
6%
Alternate Day
6%
FAQs
Is Religrast 300mcg Injection safe?
Religrast 300mcg Injection is safe if used at prescribed doses for the prescribed duration as advised by your doctor.
How does Religrast 300mcg Injection work?
Religrast 300mcg Injection works by stimulating the bone marrow (organ in the body where blood cells are produced) to increase the production of specific types of blood cells called neutrophils that help fight infections.
What are the uses of Religrast 300mcg Injection?
Religrast 300mcg Injection is used during cancer treatment (chemotherapy), bone marrow transplantation, severe chronic neutropenia (low number of a type of white blood cells called neutrophils), neutropenia in patients with HIV infection, and before stem cell donation.
Does Religrast 300mcg Injection cause cancer?
No, Religrast 300mcg Injection does not cause cancer.
Why does Religrast 300mcg Injection cause bone pain?
The exact cause in unknown, but bone pain is a common side-effect of Religrast 300mcg Injection.
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Kaushansky K, Kipps TJ. Hematopoietic Agents: Growth Factors, Minerals, and Vitamins. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1074-75.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 545-46.
- Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006. Filgrastim. [Updated 2019 Jun 3]. [Accessed 18 Feb. 2020] (online) Available from:
- Central Drugs Standard Control Organisation (CDSCO). [Accessed 27 Mar. 2019] (online) Available from:
Marketer details
Name: Reliance Life Sciences
Address: Dhirubhai Ambani Life Sciences Centre, R-282, TTC Area of MIDC, Thane-Belapur Road, Rabale, Navi Mumbai 400 701
Country of origin: India
Lab tests offered by us
Related/Popular tests
DISCONTINUED
We do not facilitate sale of this product at present